As of Wednesday, December 31, SELLAS Life Sciences Group, Inc.’s SLS share price has surged by 7.10%, which has investors ...
Stocktwits on MSN
Why is SLS stock drawing significant investor attention today?
The company said that 72 out of the prespecified 80 deaths required to trigger the final analysis have now occurred as of Dec ...
SELLAS Life Sciences Group climbs higher after a premarket drop, reversing course as investors seem to react to new ...
Stocktwits on MSN
SLS stock has risen 78% in a month — what’s the retail buzz about?
SELLAS released positive results from its Phase 2 clinical trial for an investigational leukemia drug in early December. ・The ...
Last year we predicted the arrival of the first US recession since 2009 and we told in advance that the market will decline by at least 20% in (Recession is Imminent: We Need A Travel Ban NOW). In ...
SELLAS Life Sciences Group (SLS) is back on traders’ radar after fresh data from its leukemia program, including strong response rates and supportive FDA designations, helped spark a sharp move in the ...
The average one-year price target for SELLAS Life Sciences Group (NASDAQ:SLS) has been revised to 7.14 / share. This is an increase of 16.67% from the prior estimate of 6.12 dated October 31, 2023.
NEW YORK, May 26, 2021 /PRNewswire/ -- Bruderman Brothers, LLC ("Bruderman Brothers"), is pleased to announce the successful sale of HealthEx Corporation ("HealthEx") to Associated Courier, Inc. ("ACI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback